This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr Cole Seifert, PhD
Research & Technology Specialist at Croda Inc.
Speaker

Profile

Dr. Cole Seifert obtained his Bachelor’s and PhD in Chemistry from Texas Tech University. During his PhD research, Dr. Seifert invented Group-Assisted Purification (GAP) Peptide Synthesis Technology and secured investment to commercialize the technology via the startup company, GAP Peptides, LLC. From 2017 – 2022 he served as GAP Peptides’ President and Chief Scientific Officer, and led the development of scalable, sustainable methods for peptide and biopolymer synthesis. Following acquisition of GAP Technology by Croda, Inc. in 2022, Dr. Seifert now leads peptide development activities at Croda.